Almac Sciences, an established, leading contract development and manufacturing organisation provides services for all stages of drug development for small molecules and peptides. Our expertise includes: API supply (preclinical to commercial manufacture); drug product development; stable and 14C radiolabelling; solid state services; biocatalysis, all of which are fully supported by a dedicated analytical team. Our biocatalysis team has expertise in enzyme engineering, enzyme supply, enzyme screening, developing new routes and manufacturing at scale, both GMP and non-GMP.
Protéus by Seqens
Protéus is a pioneer in protein engineering technologies, with now 20 years expertise in developing tailored enzymes and scaling-up biocatalytic processes. Protéus is an affiliate of Seqens, an integrated global leader in pharmaceutical synthesis and specialty ingredients, delivering custom-made products and solutions to its customers. Seqens operates 24 industrial plants and 3 R&D centers in Europe, North America and Asia. More than 300 scientists, engineers and experts develop tailor-made solutions for its customers and ensure that products are successfully transferred into production.